Abstract
Objective: To evaluate the efficacy of Jiawei Huangqi Guizhi Wuwu Decoction (JHGWD) in treating neuro-sensory toxicity induced by oxaliplatin.Methods: A randomized controlled self-crossover trial was performed. Thirty-one patients were randomly divided into AB and BA groups. Patients in A cycle belonged to the treated group, who were treated with chemotherapy combined with oxaliplatin plus JHGWD. Patients in B cycle belonged to the control group and were treated with chemotherapy alone. The peripheral neuro-sensory toxicity was observed and analyzed.Results: The main neurotoxicity was cold-induced paresthesia after the use of oxaliplatin, which included hyperaesthesia, chill, anaesthesia in the extremities, electrified sensation, formication, foreign body sensation and pain that might be exacerbated by exposure to cold. Twenty patients (64.5%) suffered from neuro-sensory toxicity in the treated group and 27 cases (87. 1%) in the control group. Symptoms were more serious and lasted longer in the control group than those in the treated group (P<0.01).Conclusion: JHGWD could prevent and reduce the occurence and intensity of acute peripheral neuro-sensory toxicity caused by oxaliplatin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Feng B, Yu JM, Guo QS, et al. Observation of affection on advanced stomach cancer of oxaliplatin. Chin J Cancer Prev Treat 2004; 11(3): 301–303.
Betheault-Cvitkovic F, Jami A, Ithzaki M, et al. Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leuovorin in patients with metastatic colorectal cancer. J Clin Oncol 1996; 14: 2950–2958.
Wang MP, Ma LW, Zhang SL, et al. Clinical study of peripheral neuro-sensory toxicity caused by the regimen combined with oxaliplatin treating colorectal cancer. Chin J Cancer Prev Treat 2004; 11(2): 168–170.
Su QG, Che CY. Clinical study of oxaliplatin. Foreign Med Sci: Oncol Sect 1999; 26(4): 208–210.
Raymond E, Chaney SG, Taama A, et al. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol 1998; 9(10): 1053–1071.
Hu GQ, Fu Q, Jin ML, et al. Clinical study of oxaliplatin combined with hydroxycamptothecin, flurouracil, folinic acid treating 36 advanced gastric cancer. Chin J Clin Oncol 2004; 31(9): 506–512.
Armand JP, Su Y, Guan ZZ, et al. Oxaliplatin in the treatment of advanced colorectal cancer—a review of clinical studies. Cancer 1999; 18(6): 624–630.
Cersosimo RJ. Oxaliplatin-associated neuropathy: a review. Ann Pharmacother 2005; 39(1): 128–135.
Screnci D, Er HM, Hambleg TW. Stereoselective peripheral sensory neurotoxicity of diaminocy clohexane platinum enantiomes related to ormaplatin and oxaliplatin. Br JCancer1997; 76(4): 502–510.
Grolleau F, Gamelin L, Boisdron-Celle M, et al. A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels. J Neurophysiol 2001; 85(5): 2293–2297.
McKeage MJ, Hsu T, Screnci D, et al. Nucleolar damage correlates with neurotoxicity induced by different platinum drugs. Br J Cancer 2001; 85(8): 1219–1225.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yuan, L., Hui-juan, G., Jin-chang, H. et al. Clinical study of Jiawei Huangqi Guizhi Wuwu Decoction in preventing and treating peripheral neuro-sensory toxicity caused by oxaliplatin. Chin. J. Integr. Med. 12, 19–23 (2006). https://doi.org/10.1007/BF02857424
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02857424